Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Jeffrey Zwicker

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5810-6893; OpenAlex author ID A5007341838; NIH RePORTER profile ID 8342596. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 0, last author 1)
Trials
2 (principal investigator on 2)
Grants
2
Labs led
1
Collaborators
4
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: 1 grant · 2012: none · 2013: none · 2014: none · 2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 grant

Papers 1

  1. Discordant reporting of VTE in pancreatic cancer: A systematic review and meta-analysis of thromboprophylaxis versus chemotherapeutic trials. Last author DOI 10.1111/jth.15175↗

Trials 2

  1. Cancer Associated Thrombosis and Isoquercetin (CATIQ) Principal investigator NCT02195232↗
  2. Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles Principal investigator NCT00908960↗

Grants 2

  1. Biomarkers and mechanisms in cancer associated thrombosis U01HL143365↗
  2. Bloodborne tissue factor-bearing microparticles in Trousseau's syndrome K23HL084052↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elliot Chaikof · 1 shared grant, 2022 · strength 0.52
  2. Robert C Flaumenhaft · 1 shared grant, 2022 · strength 0.52
  3. Thita Chiasakul · 1 shared paper, 2021 · strength 0.17
  4. Anthony Maraveyas · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.